The proposed bill, H.B. No. 2025-2026, seeks to enact section 124.826 of the Revised Code, which establishes a reimbursement program for state employees and elected officials for out-of-pocket costs associated with GLP-1 drugs, a class of medications used for chronic weight management. The bill defines key terms such as "GLP-1 drug," "pharmacy," and "physician," and outlines the eligibility criteria for reimbursement. Specifically, reimbursements will be available for a maximum of twenty-four consecutive months, with specific conditions regarding the purchase of the drugs and the requirement for proof of a qualifying body mass index.

Under the bill, eligible individuals can apply for reimbursements of up to $500 per month during the first year and up to $250 per month during the second year of eligibility. The bill also includes provisions for reapplying for reimbursements after a six-month waiting period, contingent upon a significant weight increase. The director of administrative services is tasked with determining eligibility and implementing the program through rules established in accordance with Chapter 119 of the Revised Code.